Recent news on Candesartan

Actos drives growth at Takeda but Januvia threat is hovering  -  May 11, 2007
Pharma Times (subscription),Blood pressure drug Blopress (candesartan cilexetil) posted a 8% increase in sales to 206.2 billion yen, though gastrointestinal drug Takepron

Lowering Blood Pressure Following Stroke May Reduce Damage  -  Apr 23, 2007
Medical News Today (press release),The rats given candesartan, however, showed the additional benefit of improved function while the rats receiving the other blood pressure medications had

Lowering blood pressure following stroke may reduce damage  -  Apr 18, 2007
SpiritIndia,The rats given candesartan, however, showed the additional benefit of improved function while the rats receiving the other blood pressure medications had

Angiotensin receptor blockade and angiotensin-converting-enzyme ...  -  Apr 12, 2007
HeartZine,To determine whether therapy with the angiotensin II type 1 receptor blocker (ARB) candesartan and the comparator angiotensin-converting-enzyme inhibitor

Atacand HCT Medicine - Uses, Dosage & Side Effects  -  Apr 18, 2007
American Chronicle,Therapy with any combination of candesartan cilexetil and hydrochlorothiazide will be associated with both sets of dose-independent side effects.

From metabolic syndrome to diabetes: Is it all about the blood ...  -  Jan 31, 2007
TheHeart.Org,Over a 10-month period, each patient participated in three treatment arms—ramipril 10 mg and placebo, candesartan 16 mg and placebo, or the combination of

Sales strong for Takeda but pressure to expand is on  -  Feb 1, 2007
Pharma Times (subscription),Blood pressure drug Blopress (candesartan cilexetil) posted a 5.7% increase in sales to 157.1 billion yen, though gastrointestinal drug Takepron

UK could save a billion on cholesterol and blood pressure drugs ...  -  18 Jan 2007
innovations report,...“In this study the generic drug simvastastin replaced low dose atorvastastin for high cholesterol treatment and candesartan replaced losartan for treating

Health providers could save billions without compromising ...  -  Jan 17, 2007
EurekAlert (press release),..."In this study the generic drug simvastastin replaced low dose atorvastastin for high cholesterol treatment and candesartan replaced losartan for treating

Heart failure: combined use of Candesartan and Ace inhibitor ...  -  Dec 22, 2006
Xagena.it,An analysis from the CHARM-Added trial provided evidence that the clinical benefits of Candesartan ( Atacand / Ratacand ) in reducing the risk of

Heart failure: combined use of Candesartan and Ace inhibitor ...  -  Dec 22, 2006
Xagena.it,An analysis from the CHARM-Added trial provided evidence that the clinical benefits of Candesartan ( Atacand / Ratacand ) in reducing the risk of

Drug Therapy for Prehypertension Questioned  -  Dec 19, 2006
Journal of American Medical Association (subscription),In that study, the Trial of Preventing Hypertension (TROPHY), participants were randomly assigned to receive an angiotensin II receptor blocker, candesartan

Japan's Takeda H1 opg profit hits record high on brisk drug sales ...  Nov 5, 2006
Sales of its hypertension treatment drug candesartan, sold under the brand name Blopress, rose 8.3 pct to 100.9 bln yen from a year earlier. ... -Forbes, Prominent Hypertension Specialists Question Results of TROPHY ...  Oct 27, 2006
The recent Trial of Preventing Hypertension (TROPHY) examined whether treating patients with candesartan for two years resulted in a sustained reduction in the ... -innovations report, Incidence of hypertension reduced with early intervention  Oct 17, 2006
..." We chose to administer a low dose of Candesartan cilexetil ( Atacand/Ratacand ) because it has qualities that suggest it changes characteristics of the blood ... -Xagena.it, Healthcare: FH Remedy wins Takeda Euro job  Oct 20, 2006
The new contract will continue The Remedy's work on medical meetings to support Actos (pioglitzone), Blopress (candesartan) and leuprorelin, but includes ... -Therapeutics Daily (subscription) (press release), The results of CASE-J study, the first large-scale clinical study ...  Oct 19, 2006
This is the first large-scale outcome study in Japan comparing Blopress®, (generic name: candesartan cilexetil), angiotensin receptor blocker and Amlodipine ... -PipelineReview.com (press release), Benefits of Candesartan added to ACE inhibitor in inhibition of ...  Sep 2, 2006
A study assessed if adding Candesartan ( Atacand ) to ACE ( angiotensin-converting enzyme ) inhibitors would delay progression of nephropathy in hypertensive ... -Xagena.it

Atrial fibrillation incidence in chronic heart failure patients is ...  Sep 21, 2006
Treatment with the angiotensin receptor blocker candesartan reduced the incidence of atrial fibrillation in a large, broadly-based, population of patients with ... -Therapeutics Daily (subscription)

Incidence of hypertension reduced with early intervention  Aug 25, 2006
..." We chose to administer a low dose of the ARB medication Candesartan cilexetil ( Atacand/Ratacand ) because it has qualities that suggest it changes ... -Xagena.it

Mac research alters thinking on the cause of heart disease  Sep 8, 2006
Another series of papers on a study called CHARM, published in 2003, has been widely cited after finding a medication called candesartan helped keep heart ... -Hamilton Spectator

Researchers' data from Scotland, Japan and the United States ...  Aug 31, 2006
States. Study 1: Angiotensin-converting enzyme (ACE) inhibitors add to the benefits of candesartan in the treatment of heart failure. ... -Therapeutics Daily (subscription)

-- Coversyl(R) in PEP-CHF Trial, is the First Agent to Demonstrate ...  Sep 3, 2006
...receptor blocker (ARB) efficacy in a population of heart failure patients with preserved left ventricular ejection fraction (LVEF), candesartan did not achieve ... -Europa Press

Ramipril Combined With Candesartan Plus ACE Inhibitor Shows ...  -  Nov 17, 2006
DG NewsCHICAGO, IL -- November 17, 2006 -- Combining the angiotensin converting enzyme inhibitor ramipril with the angiotensin receptor blocker candesartan gives

I-PRESERVE) Trial -- Study Population Compared With "Real Life ...  -  Nov 14, 2006
Medscape (subscription)Both PEP-CHF and the other, larger trial carried out in patients with preserved LV systolic function, the Candesartan in Heart Failure--Assessment of

Incidence of hypertension reduced with early intervention  Aug 25, 2006
..." We chose to administer a low dose of the ARB medication Candesartan cilexetil ( Atacand/Ratacand ) because it has qualities that suggest it changes ... -Xagena.it

Treating Prehypertension  Jul 26, 2006
...of the efficacy of candesartan for prehypertension (April 20 issue) 1 demonstrates what seemed obvious: if patients with prehypertension receive hypotensive ... -New England Journal of Medicine (subscription)



Treatment With Candesartan Brings Added Benefit to Heart Failure ...  May 4, 2006
In these analyses of the CHARM*-Added trial the benefit of adding candesartan to baseline treatment was maintained in subgroups of HF patients taking either a ... - DG News

Combined Use of ATACAND(R) (candesartan cilexetil) and ACE ...  May 4, 2006
WILMINGTON, Del., May 4 /PRNewswire-FirstCall/ -- AstraZeneca today announced the publication of a supplemental analysis from the Candesartan in Heart failure ... - Finanzen.net

Combined Use of ATACAND (candesartan cilexetil) and ACE Inhibitor ...  May 4, 2006
WILMINGTON, Del., May 04, 2006 /PRNewswire-FirstCall/ -- AstraZeneca today announced the publication of a supplemental analysis from the Candesartan in Heart ... - PharmaLive.com

Experts Ponder Treating Prehypertension  May 9, 2006
...the American College of Cardiology's annual Scientific Session in Atlanta in March suggested that treatment of prehypertension with candesartan, an angiotensin ... - Journal of American Medical Association (subscription)

Takeda Eyeing Prescription Drug Sales of 1.4 Tril. Yen By FY 2010  May 11, 2006
...sales of Pioglitazone, used to treat diabetes, rose 26.3 percent to 243.8 billion yen, and those of the anti-hypertension drug Candesartan rose 25.5 percent to ... - International News Service

Combined Use Of Atacand(R) And ACE Inhibitor Improves Heart ...  May 5, 2006
...(NYSE:AZN) today announced the publication of a supplemental analysis from the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity ... - Medical News Today

Feasibility of Treating Prehypertension with an Angiotensin ...  Apr 19, 2006
...pressure of 139 mm Hg or lower and diastolic pressure of 85 to 89 mm Hg, were randomly assigned to receive two years of candesartan (Atacand, AstraZeneca) or ... - New England Journal of Medicine (subscription)

Novel Study Published In New England Journal Of Medicine Evaluates ...  Apr 21, 2006
...in this four-year trial, there was a significant (15.6 percent) relative risk reduction in the group treated with ATACAND(R) (candesartan cilexetil), compared ... - Medical News Today

Takeda Announces "2006-2010 Medium-Term Management Plan" - Growth ...  May 11, 2006
Leuprorelin, Lansoprazole, Candesartan and Pioglitazone Focusing on Takeda-ism, which represents the corporate philosophy referring to "Integrity = fairness ... - PharmaLive.com

AstraZeneca's ATACAND Effective In Treating Patients With ...  Apr 20, 2006
...patients with prehypertension. The patients were given ATACAND or candesartan cilexetil in dosage of 16 mg once daily. Blood pressure ... - Trading Markets



Botox shots may help kids who have cerebral palsy  Feb 12, 2006
...finds. Researchers analyzed data on 2,680 North American patients who took part in a study involving the drug candesartan. "Notably ... - Indianapolis Star,

Kidney Trouble Speeds Heart Failure  Feb 6, 2006
...study finds. Researchers analyzed data on 2,680 North American patients who took part in a study involving the drug candesartan. "We ... - Forbes

Music, Healing Touch May Aid Recovery  Jan 16, 2006
New analysis of a major heart failure study demonstrates that patients treated with Atacand (candesartan) to lower blood pressure reported greater improvement ... - Saturday Evening Post

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional